It has been reported that m6A writers (METTL3, METTL14, METTL16), erasers (FTO, ALKBH5) and readers (IGF2BP family, YTHDC1) are all involved in regulating AML progression [27–31]. Here, FTO is linked to acute myeloid leukemia.